Journal Policy 4: Research & Publication Ethics Policy

Journal Policy 4

The Asian Journal of Cognitive Behavior Therapy (AJCBT) promotes research integrity and adherence to the core values of research: objectivity, honesty, openness, fairness, accountability, and stewardship. AJCBT expects authors to uphold a culture of responsible research.

AJCBT follows the core practices of the Committee on Publication Ethics (COPE) and deals with any suspected misconduct as per COPE guidelines. The journal also follows the Ethical Principles of Psychologists and Code of Conduct of the American Psychological Association (APA), the World Medical Association (WMA) Declaration of Helsinki, and the authorship criteria of the International Committee of Medical Journal Editors (ICMJE).

Research Ethics Committee Approval

  • Authors must provide approval, or a formal exemption, from an institutional ethics review board/committee for all research involving human participants at the time of submission.
  • Where applicable, authors must also submit written permission from the institution, clinic, or service where the research was conducted.
  • Authors must state in the Method section the name of the approving committee and that procedures followed its ethical standards and the latest version of the Declaration of Helsinki.
  • If there is suspicion that research was not conducted within an appropriate ethical framework, the Editor will follow the relevant COPE procedures. AJCBT may reject a manuscript — even if ethics approval has been obtained — and/or contact the authors’ ethics committee.

Protection of Research Participants

Research on psychological therapies often involves people who are distressed or vulnerable. AJCBT expects authors to show how participants were protected throughout the study:

Informed Consent

  • Informed consent must be obtained from all adult participants, and from a parent/guardian for participants under 18, together with the young person’s own assent. This must be documented in the Method section.
  • Consent must be sought in a language and format participants understand. Where participants have limited literacy, verbal consent may be accepted if witnessed and documented, and approved by the ethics committee.
  • Where family members are involved in decisions, as is common in many South Asian settings, the individual consent of each adult participant is still required.
  • Participants must be told that taking part is voluntary, and that they may withdraw at any time without any effect on their access to care or treatment.
  • Where deception is essential to a study design, it must be approved by the ethics committee, and participants must be fully debriefed.

Vulnerable Participants

Additional safeguards are required when research involves children and adolescents, people with severe mental illness or cognitive impairment, people in inpatient, forensic, or custodial settings, refugees and displaced people, or others whose capacity for free and informed consent may be limited. Authors should describe these safeguards, including how capacity to consent was assessed.

Risk Management and Participant Safety

  • Authors must describe the procedures used to identify and respond to risk during the study — in particular suicidality, self-harm, and severe distress — including referral pathways to appropriate care.
  • Adverse events and possible harms of psychological interventions should be monitored and reported, including deterioration and dropout due to adverse effects.
  • The use of waiting-list, treatment-as-usual, or other control conditions must be ethically justified, and participants in control conditions should be offered access to effective treatment when the study ends, where possible.
  • Interventions should be delivered by appropriately trained therapists under clinical supervision.

Confidentiality

  • Participants’ names, initials, clinical record numbers, and other identifying details must not appear anywhere in the manuscript, tables, figures, or supplementary files.
  • Session recordings, transcripts, and clinical notes must be stored securely, and used only as consented by participants and approved by the ethics committee.
  • Qualitative quotations must be de-identified and must not include details that could identify the participant or others.
  • Where anonymity cannot be assured, specific written consent to publication must be obtained.
  • Retrospective studies of clinical records may be conducted without individual consent only when using de-identified data and with explicit approval of the ethics committee for a waiver of consent.

Case Reports

  • Written informed consent to publication must be obtained from the client (or guardian) for all case reports, and made available to the Editor on request. Consent forms are treated confidentially.
  • Non-essential identifying details (e.g., age, occupation, location, family details) should be altered, and authors must confirm that the alterations do not distort the clinical meaning of the case.
  • Authors are advised to follow the CARE guidelines.

Research Involving Animals

AJCBT does not normally publish research involving animals. Any such submission must show approval from an appropriate animal ethics committee and compliance with the ARRIVE guidelines.

Authorship

All persons designated as authors should qualify for authorship. To qualify as an author, one should meet all 4 ICMJE criteria:

  • 1) Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data; AND
  • 2) Drafting the manuscript or revising it critically for important intellectual content; AND
  • 3) Final approval of the version to be published; AND
  • 4) Agreement to be accountable for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Delivering therapy, collecting data, acquiring funding, or general supervision of the research group, alone, does not justify authorship; such contributions should be recognized in the Acknowledgments. Any issue related to authorship — including ghost, guest, and gift authorship — will be dealt with as per COPE guidelines.

Plagiarism

  • All articles submitted to AJCBT are screened through plagiarism-detection software. In line with the HEC Plagiarism Policy, the overall similarity index must be below 19%.
  • AJCBT follows the standard definition of plagiarism and endorses COPE and HEC policies on plagiarism.
  • It is the authors’ responsibility to be aware of all forms of plagiarism — plagiarism of ideas, text, and paraphrasing; self-plagiarism (including redundant or duplicate publication); salami slicing (data fragmentation); and text recycling. Ignorance of plagiarism will not be considered an excuse.
  • Any manuscript — submitted, accepted, or already published — found to be plagiarized will be dealt with according to COPE guidelines.
  • The Editor will immediately stop the processing or publication of the article and request an explanation from the authors. The corresponding author must respond within 30 days of notification.
  • If an acceptable explanation is provided, the Editor may recommend appropriate changes, after which the review process may resume.
  • In cases of non-response or an unsatisfactory explanation, the Editor will determine the appropriate course of action, which may include:
  • Rejection of the manuscript
  • Retraction of an already published article
  • Debarment of the author(s) from future publication in AJCBT for one year or permanently, depending on the severity of the offence
  • Placing the author(s) under watch for future submissions
  • Notifying the Higher Education Commission (HEC) and the author’s institution for information and possible action
  • The author(s) will be required to provide documentary proof of retraction from another publication, if such a defense is pleaded.
  • Those claiming theft of ideas or data must provide documentary proof in support of their claim.